Alfie W
Author:
Dr Dave Tittle | BVetMed | CertVA | MRCVS | GP Certificate in Western Veterinary Acupuncture and Chronic Pain Management | RCVS Advanced Practitioner Veterinary Anaesthesia
Contact:
To correspond with Dr Tittle please e-mail us at customersupport@ellevancesciences.co.uk
Case History
- Name: Alfie W
- Age: 10 years 4 months
- Sex: ME
- Species: Dog
- Breed: Collie X
- Lifestyle: Sedentary
- A brief history of the animal’s family history:
Rescued from DogsTrust around four years old. History of seizures, which are managed by standard veterinary anti-epileptics. - Interventions:
Advised strict weight loss regime – to date this has not been successful.
- A brief history of the problem which animal is being treated for:
Cluster seizures weekly, despite current medications. Potassium bromide made unacceptably sedate. Anxious dog, who likes routine. The owner feels that anxiety may trigger seizures, which are usually at home and at night.
Examination findings
General observations/Assessment:
Overweight at 46kg (BCS 4.5/5)
He usually seizes in his sleep and at night, although his owners cannot predict them, nor identify a set pattern. They do feel he is an anxious dog who likes his routine, so changes in this may affect him.
Tests results:
Routine Chem 17 bloods showed a mildly increased ALT and ALKP. A phenobarbitone assay was within therapeutic range.
Neurological testing :
Normal neurological exam.
Pain assessment:
| Exam | Hudson Pain Score |
| Initial | 1.75 |
| Last exam | 1.25 |
Gait Assessment:
| Exam | Generalised lameness |
| Initial | 3/10 |
| Last exam | 2/10 |
Supportive media:
(click image to enlarge)
Treatment
Current Medication
| Active | Proprietary name | Dose |
| Imepitoin | Pexion | 800mg BID |
| Phenobarbitone | Epityl | 150mg BID |
| Levetiracetam | Keppra | 500mg TID |
New Treatment
| Active | Proprietary name | Dose |
| CBD/CBDA/Terpene | ElleVance | 70mg BID |
| Dosed 2mg/Kg based on lean body weight |
Special instructions:
Aim to increase the exercise regime and weight loss.
Owner education:
Strive to decrease weight, especially as his mobility improves. Requested to keep a seizure diary.
Measurable outcomes and Conclusion
Outcome:
Seizure frequency has decreased from one weekly to approximately one fortnightly following the addition of ElleVance, in addition to recognised anti-epileptic therapeutics. Seizures only occurred when his owners have been away from home, and Alfie has been looked after by their daughter. Besides, a notable improvement in mobility has been noted. He remains overweight – weight loss has been unsuccessful.
Remaining problems and goals:
Weight management, which will inevitably increase his mobility and quality of life.
Conclusion/ Discussion:
Addition of Ellevance appears to have decreased seizure frequency and has reduced the duration and severity of seizures.
